News
Despite significant advancements in spinal muscular atrophy (SMA) management, unmet needs persist, especially for patients ...
Parents of children with spinal muscular atrophy (SMA), a rare disease, welcomed the announcement by the Indian pharma ...
FDA-approved treatments for spinal muscular atrophy differ in their mechanisms of action, safety profiles, and administration ...
Manchester United captain Bruno Fernandes has issued a message after he was joined by a disabled mascot at Old Trafford ahead ...
Affordable generic version of SMA drug Risdiplam soon available in India, offering hope to patients and activists.
Onasemnogene abeparvovec for treating spinal muscular atrophy in people 2 years and over [TSID12168]
Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...
Funding medical research is about more than just numbers. It's real people,” says Ryan Manriquez, president of the UC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results